Entera Bio (ENTX) Property, Plant & Equipment (Net) (2017 - 2026)

Entera Bio (ENTX) Property, Plant & Equipment (Net) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 Entera Bio 186.78 Mn 182.64 Mn - 127,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 127,000.00
Mar 31, 2026 127,000.00
Dec 31, 2025 134,000.00
Dec 31, 2025 134,000.00
Sep 30, 2025 114,000.00
Sep 30, 2025 114,000.00
Jun 30, 2025 79,000.00
Jun 30, 2025 79,000.00
Mar 31, 2025 57,000.00
Mar 31, 2025 57,000.00
Dec 31, 2024 57,000.00
Dec 31, 2024 57,000.00
Sep 30, 2024 65,000.00
Sep 30, 2024 65,000.00
Jun 30, 2024 76,000.00
Jun 30, 2024 76,000.00
Mar 31, 2024 87,000.00
Mar 31, 2024 87,000.00
Dec 31, 2023 100,000.00
Dec 31, 2023 100,000.00